ISRCTN44737909已完成未知
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder.A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months.
Institut de Recherches Internationales Servier (France)0 个研究点目标入组 130 人开始时间: 2007年6月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/21829106
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged between 18 and 60 years
- •2. Male or female
- •3. Fulfilling Diagnostic and Statistical Manual of mental disorders fourth edition (DSM-IV-TR) criteria for major depressive disorder
排除标准
- •1. Women of childbearing potential without effective contraception as well as pregnant or breastfeeding women
- •2. All types of depression other than major depressive disorder
研究者
相似试验
进行中（未招募）
不适用
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder.A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months.MedDRA version: 8.1Level: LLTClassification code 10057840Term: Major depressionMajor Depressive DisorderEUCTR2006-004716-48-GBInstitut de Recherches Internationales Servier130
进行中（未招募）
1 期
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder.A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months.MedDRA version: 8.1Level: LLTClassification code 10057840Term: Major depressionMajor Depressive DisorderEUCTR2006-004716-48-FRInstitut de Recherches Internationales Servier130
进行中（未招募）
不适用
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder.A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months.MedDRA version: 8.1Level: LLTClassification code 10057840Term: Major depressionMajor Depressive DisorderEUCTR2006-004716-48-ATInstitut de Recherches Internationales Servier130
进行中（未招募）
不适用
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder.A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months.Major Depressive DisorderEUCTR2006-004716-48-FIInstitut de Recherches Internationales Servier130
进行中（未招募）
1 期
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder.A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months.Efecto de agomelatina (25 a 50 mg/día) sobre los parámetros electroencefalográficos del sueño comparado con escitalopram en pacientes con Trastorno Depresivo Mayor.Estudio aleatorizado doble ciego, en grupos paralelos frente a comparador durante 6 semanas, seguido de un periodo de extensión opcional doble ciego hasta un total de 6 meses de duración.Major Depressive DisorderTrastorno Depresivo MayorMedDRA version: 8.1Level: LLTClassification code 10057840Term: Major depressionEUCTR2006-004716-48-ESInstitut de Recherches Internationales Servier130